Target intelligence / Profile preview

High mobility group box 3 pseudogene 12 (HMGB3P12)

Target
HMGB3P12
Molecular classification
Pseudogene, Non-coding RNA (potential, as some pseudogenes are transcribed)
01

Overview

High mobility group box 3 pseudogene 12 (HMGB3P12) is a pseudogene, a DNA segment homologous to the protein-coding HMGB3 gene, but considered nonfunctional as it does not encode a protein. Like other pseudogenes, its sequence is highly similar to its parent gene. While pseudogenes have long been considered "junk DNA," emerging evidence shows some may have regulatory functions (e.g., as competing endogenous RNAs, microRNA decoys, or regulators of mRNA stability for their parent genes or related genes)[1][6]. However, there is no specific published evidence that HMGB3P12 encodes a protein or acts as a direct therapeutic target, nor are there known pharmacological agents that interact with it[3][5]. Its role, if any, would be in gene regulation rather than as a conventional drug target such as a receptor, enzyme, or transporter. Assessment: - HMGB3P12 is not a conventional therapeutic target; it is a non-functional pseudogene, and is not classified as a receptor, enzyme, transporter, or druggable molecule[3][5][6]. - There is no evidence for known biological function, involvement in disease, interacting drugs, or mechanisms of action specific to HMGB3P12. - If searching for a target with therapeutic relevance or drug interaction, this entry is likely incorrect or irrelevant for those purposes[2][3][5][6]. - It fits the general characteristics of a processed pseudogene per HGNC and current genetic and genomic guidelines[2][6].

02

Biological functions

Potential regulatory role (e.g., as competing endogenous RNA, microRNA decoy, or regulator of mRNA stability for parent/related genes)
03

Disease associations

No specific, direct disease role known for HMGB3P12 itself

Beyond the preview

Go deeper on High mobility group box 3 pseudogene 12 (HMGB3P12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group box 3 pseudogene 12 (HMGB3P12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call